Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
In the Phase 2 obesity trial, retatrutide 12 mg produced approximately 24.2% mean weight loss at 48 weeks ( Jastreboff et al., NEJM 2023 ), and the Phase 2 type 2 diabetes trial showed strong HbA1c and weight reductions ( Rosenstock et al., Lancet 2023 )
Addressing Underlying Factors: By addressing multiple facets of weight management, including appetite regulation and metabolism, the combination may tackle underlying factors contributing to weight gain
They work hard, train consistently, and still feel like their body is not adapting
Research Background Preclinical studies have investigated Melanotan 2 as a non-selective agonist of the melanocortin receptors MC1R through MC5R
US$ 26.63
US$ 27.43
US$ 27.77
US$ 23.98
